![William E. Yelle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William E. Yelle
Founder at Firecyte Therapeutics, Inc.
Network origin in William E. Yelle first degree
Entity | Entity type | Industry | |
---|---|---|---|
Envisia Therapeutics, Inc.
![]() Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC.
4
| Holding Company | Biotechnology | 4 |
Firecyte Therapeutics, Inc.
![]() Firecyte Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Firecyte Therapeutics, Inc. is an emerging biotechnology company based in Cambridge, MA that is focused on developing novel treatment strategies for progressive neurodegenerative diseases of the eye. The company's research is centered around the role of microglia and neuroinflammation in these diseases. The team is led by Jonathan Levenson, the Chief Scientific Officer, who has over 16 years of experience in neuropsychiatry, neurodegeneration, and neuroinflammation. The company was founded by Dong Feng Chen and William E. Yelle, who has been the CEO since incorporation.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to William E. Yelle via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Private Equity Investor | |
PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Corporate Officer/Principal | |
IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Anadys Pharmaceuticals, Inc.
![]() Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Quintiles, Inc. (California)
![]() Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Bracebridge Capital LLC
![]() Bracebridge Capital LLC Investment ManagersFinance Bracebridge Capital LLC (Bracebridge) is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded in 1994 by Nancy Zimmerman and Gabriel Sunshine. They are owned by Bracebridge Capital II LP. Bracebridge provides investment advisory services to pooled investment vehicles. | Investment Managers | Private Equity Investor | |
Ziarco, Inc. | Director/Board Member | ||
RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Canaan Management, Inc.
![]() Canaan Management, Inc. Investment ManagersFinance Canaan Management, Inc. (Canaan Management) is a venture capital firm founded in 1987 by Eric A. Young. The firm is headquartered in Westport, CT. | Investment Managers | Private Equity Investor | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Doctorate Degree | |
Massachusetts Institute of Technology | College/University | Masters Business Admin | |
Mount Holyoke College | College/University | Undergraduate Degree | |
Western Carolina University | College/University | Graduate Degree | |
Mass General Brigham Ventures LLC
![]() Mass General Brigham Ventures LLC Investment ManagersFinance Mass General Brigham Ventures LLC (Mass General Brigham Ventures) is a venture capital subsidiary of Partners Research Ventures & Licensing founded in 2005. The firm is headquartered in the Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
North Carolina State University College of Sciences Foundation | Corporate Officer/Principal | ||
Enlight Biosciences LLC
![]() Enlight Biosciences LLC Pharmaceuticals: MajorHealth Technology Enlight Biosciences LLC develops research tools for drug discovery and development. It offers patient-centric platforms that may impact all aspects of the connected health ecosystem from patient engagement and experience, to patient-focused research and development. The company was founded by Raju S. Kucherlapati, David Steinberg, Rakesh Kumar Jain, H. Robert Horbitz, and Sanjiv Sam Gambhir in July 2008 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Amplyx Pharmaceuticals, Inc.
![]() Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
AstraZeneca LP
![]() AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Empower Energies Clean Infrastructure LLC
![]() Empower Energies Clean Infrastructure LLC SemiconductorsElectronic Technology Empower Energies, Inc. operates as a full-service renewable energy program manager. It provides customized renewable energy project development, construction, financing and acquisition solutions. The company was founded by Len Jornlin in 2010 and is headquartered in Bethesda, MD. | Semiconductors | Director/Board Member | |
TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Ziarco Pharma Ltd.
![]() Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Chairman | |
OBSEVA SA | Pharmaceuticals: Major | Director/Board Member | |
Synlogic Operating Co., Inc.
![]() Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Ziarco Group Ltd.
![]() Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
RENEO PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
INOZYME PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Senti Sub I, Inc.
![]() Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
SYNLOGIC, INC. | Biotechnology | Director/Board Member | |
AKOUOS | Biotechnology | Director/Board Member | |
MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Mediar Therapeutics, Inc.
![]() Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
Shape Therapeutics, Inc.
![]() Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Shape Therapeutics, Inc. operates as a biotechnology firm. It offers genome medicine. The company was founded by Francois Vigneault and John D. Suliman in 2018 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Nocion Therapeutics, Inc.
![]() Nocion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nocion Therapeutics, Inc. is a biopharmaceutical company, which targets neurons mediating cough, itch, pain and inflammation without the addictive properties of opioids. The company was founded by Bruce Bean, Clifford Woolf and Bruce David Levy and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
MBX Biosciences, Inc.
![]() MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Director/Board Member | |
Curzion Pharmaceuticals, Inc.
![]() Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Affinia Therapeutics, Inc.
![]() Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
Code Biotherapeutics, Inc.
![]() Code Biotherapeutics, Inc. BiotechnologyHealth Technology Code Biotherapeutics, Inc. is a next-generation gene therapy company based in Greater Philadelphia. The American company is focused on developing targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. The company uses a novel multivalent synthetic DNA delivery platform called 3DNA, which overcomes many of the challenges associated with viral-based gene therapies. Code Biotherapeutics is advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward programs in both rare and prevalent diseases. Code Biotherapeutics is supported by top-tier investors that believe in their work to drive discovery programs forward as they aim to deliver on the promise of their proprietary synthetic DNA-based, non-viral genetic medicines delivery platform. The company was founded by Brian P. McVeigh, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Takeda Digital Ventures
![]() Takeda Digital Ventures Investment ManagersFinance Takeda Digital Ventures (Takeda Digital Ventures) is a venture capital subsidiary of Takeda Pharmaceutical Co., Ltd. founded in 2018. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Director/Board Member | |
SENTI BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
New Enterprise Associates, Inc. | Corporate Officer/Principal | ||
Violet Therapeutics
![]() Violet Therapeutics Medical/Nursing ServicesHealth Services Violet Therapeutics is an American healthcare company founded by Meredith Fisher. Meredith Fisher has been the CEO since incorporation. | Medical/Nursing Services | Founder |
Statistics
International
United States | 47 |
United Kingdom | 3 |
Sweden | 2 |
Switzerland | 2 |
Sectoral
Health Technology | 33 |
Finance | 6 |
Consumer Services | 4 |
Commercial Services | 3 |
Health Services | 3 |
Operational
Director/Board Member | 69 |
Independent Dir/Board Member | 18 |
Corporate Officer/Principal | 16 |
Private Equity Investor | 10 |
Chief Executive Officer | 6 |
Most connected contacts
Insiders | |
---|---|
Ed Mathers Mathers | 47 |
Stephen Bloch | 23 |
Eric Linsley | 21 |
Meredith Fisher | 13 |
Stacey Pittman | 10 |
Charles Kunsch | 1 |
Ruoxi Hu | 1 |
- Stock Market
- Insiders
- William E. Yelle
- Company connections